Explore more publications!

Technology Channel Dominica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Channel Dominica.

Press releases published on September 25, 2025

Founders Fund dan Sequoia Bertaruh AS$350 Juta pada Permulaan AI Brazil Enter dalam Pasaran Undang-Undang Paling Mencabar
 Astek fédère ses expertises dans de nouveaux bureaux à Lyon et accélère sa dynamique d’innovation autour de projets à haute valeur ajoutée
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001
ヴァルムエックス (VarmX)、日本の規制当局である医薬品医療機器総合機構 (PMDA) からリード資産VMX-C001に対する第I相試験免除を取得
TomTom launches innovative road alert assistant and app for enhanced driver experience
Basilea schliesst eine Fördervereinbarung mit BARDA für die Entwicklung des Phase-3-bereiten neuartigen oralen Antibiotikums Ceftibuten-Ledaborbactam ab
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
Octane11 Integrates with LinkedIn’s Company Intelligence API, Bringing New Transparency to B2B Marketers
H1 25 Results Confirm the Relevance of Roquette’s Strategy
Les résultats semestriels confirment la pertinence de la stratégie de Roquette
Santhera gibt Update zur Wandelanleihe vom  23. September 2025 bekannt
Santhera Provides Update on Convertible Bond Issued on 23 September 2025
Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi
Intermap Technologies Files Prospectus Supplement
Neura Secures Backing from Top Investors and Cultural Icons
MBX Biosciences Announces Pricing of Upsized Public Offering
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions